Axonis Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
75 Kneeland St Fl 14, Boston, Massachuse...Website
www.axonis.usRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Axonis Therapeutics
Founded in 2019, based out of Cambridge, MA, AXONIS Therapeutics, Inc. is a biotechnology company based in Cambridge, MA, committed to developing groundbreaking therapies for spinal cord injury, and other currently incurable neurological disorders. AXONIS is advancing two breakthrough discoveries, KCC2 upmodulation to reactivate spared tissue and PTEN inhibition to regenerate injured nerve connections, to make a real difference for patients, their families, and the global healthcare system.Explore more
Axonis Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Axonis Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Axonis Therapeutics is spiking on competitors!
Check if Axonis Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Axonis Therapeutics
Funding: Get notified immidiatlly once Axonis Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Axonis Therapeutics had a recent Job posting/layoffs
Axonis Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Axonis Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Axonis Therapeutics launches new products
Recommended Actions
Reach out to Masked Content who joined Axonis Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Axonis Therapeutics
Compare insights from companies similar to Axonis Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Axonis Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Axonis Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Axonis Therapeutics.
Axonis Therapeutics financials insights
Gather financial insights about Axonis Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Angel/Seed
$4M
2021
Unspecified
$5M
2024
Series A
$115M
Axonis Therapeutics Tech Stack
A closer look at the technologies used by Axonis Therapeutics
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Funding
Funding
Funding
Project
Award, Spending/Investment
Funding
Funding
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Axonis Therapeutics
Sign Up For FreeTo access detailed company insights
Founded in 2019, based out of Cambridge, MA, AXONIS Therapeutics, Inc. is a biotechnology company based in Cambridge, MA, committed to developing groundbreaking therapies for spinal cord injury, and other currently incurable neurological disorders. AXONIS is advancing two breakthrough discoveries, KCC2 upmodulation to reactivate spared tissue and P... Read More
